<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00827645</url>
  </required_header>
  <id_info>
    <org_study_id>112008-033</org_study_id>
    <nct_id>NCT00827645</nct_id>
  </id_info>
  <brief_title>Uterine Artery Embolization and Pelvic Floor Symptoms</brief_title>
  <official_title>Effect of Uterine Artery Embolization on Symptoms of Pelvic Floor Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether women who are already receiving treatment
      for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual
      dysfunction as well.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    never funded and never started
  </why_stopped>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Actual">January 1, 2013</completion_date>
  <primary_completion_date type="Actual">January 1, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary symptoms as demonstrated by questionnaires</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sexual dysfunction as defined by questionnaires</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Leiomyoma</condition>
  <condition>Incontinence</condition>
  <condition>Prolapse</condition>
  <arm_group>
    <arm_group_label>Uterine artery embolization</arm_group_label>
    <description>Women with symptomatic uterine fibroids scheduled for uterine artery embolization</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women with symptomatic uterine fibroids who are scheduled for uterine artery embolization
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female

          -  age 18-80 years

          -  symptomatic uterine fibroids

          -  scheduled for UAE

          -  Negative urine dipstick (negative result = trace or less for leukocytes &amp; nitrites) or
             negative UA or negative culture (Urine dipstick is performed as standard of care)

          -  Available for 12-months of follow-up and able to complete study assessments, per
             clinician judgment

          -  Signed consent form

        Exclusion Criteria:

          -  Age &lt;18 or &gt;80 years

          -  women who are unable to read and write English,

          -  pregnancy or planned pregnancy in the next 12 months

          -  &lt; 6 months postpartum

          -  current use of anticholinergic medication, cholinergic agonists, tricyclic
             antidepressants, or duloxetine - must have been off such drugs for at least 4 weeks

          -  women with surgery for urinary incontinence or pelvic organ prolapse in the past 6
             months

          -  history of bladder or pelvic cancer or pelvic radiation therapy

          -  prior augmentation cystoplasty

          -  urethral diverticulum, current or repaired.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clifford Y Wai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2009</study_first_submitted>
  <study_first_submitted_qc>January 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2009</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

